ArticleEinstein (Sao Paulo, Brazil)2025
Pulmonary nodules near fissures in hepatocellular carcinoma: assessing their clinical significance.
Article in Einstein (Sao Paulo, Brazil), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate whether pulmonary nodules adjacent to fissures, particularly perifissural nodules detected on chest computed tomography in patients with hepatocellular carcinoma, can be reliably classified as benign based on their radiological characteristics.
methodsThis retrospective cohort study included patients diagnosed with hepatocellular carcinoma (LI-RADS 5) between 2018 and 2022 at two reference hospitals. The patients underwent at least two follow-up chest computed tomography scans, with a minimum interval of 1 year, to identify at least one pulmonary nodule adjacent to the fissures. Statistical analyses were performed to assess the nodule classification, growth rates, and their association with metastatic progression.
resultsIn total, 55 patients (mean age 62.4±7.7 years) and 92 nodules were analyzed. Perifissural nodules were classified as typical (n=55, 59.8%), atypical (n=17, 18.5%), or non-perifissural nodule (n=20, 21.7%). Only two nodules (2.2%) progressed to metastasis: one non-perifissural nodule and one atypical perifissural nodule with histopathological confirmation. Statistical analysis did not reveal a significant association between perifissural nodule classification and metastatic progression (p=0.155); however, nodules that progressed to metastasis exhibited significantly higher annual growth rates (p<0.001).
conclusionMost perifissural nodules in patients with hepatocellular carcinoma showed radiological stability and did not progress to metastasis, indicating a low probability of malignancy. However, given the limited sample size and the number of metastatic events, these findings should be interpreted with caution. Typical perifissural nodules may be considered low risk, whereas atypical perifissural nodule and non-perifissural nodules require closer follow-up. Further studies are required to confirm these preliminary findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.